Series Fund - Developing Growth Portfolio
Summary
Summary
The Fund seeks to deliver long-term growth of capital by investing primarily in stocks of small U.S. companies.
Holding | Sector | Assets |
---|
Cava Group Inc | Consumer Discretionary | 2.2% |
CyberArk Software Ltd | Information Technology | 2.1% |
Zeta Global Holdings Corp | Information Technology | 2.1% |
Glaukos Corp | Health Care | 2.1% |
Piper Sandler Cos | Financials | 2.1% |
TransMedics Group Inc | Health Care | 2.0% |
Varonis Systems Inc | Information Technology | 1.9% |
Sweetgreen Inc | Consumer Discretionary | 1.9% |
Comfort Systems USA Inc | Industrials | 1.9% |
ADMA Biologics Inc | Health Care | 1.9% |
Ten largest holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund’s current or future investments. The figures presented are as of the date shown, do not include the Fund’s entire investment portfolio, and may change at any given time.
Holding | Sector | Assets |
---|
Glaukos Corp | Health Care | 2.2% |
TransMedics Group Inc | Health Care | 2.2% |
CyberArk Software Ltd | Information Technology | 2.1% |
Cava Group Inc | Consumer Discretionary | 2.1% |
Piper Sandler Cos | Financials | 2.0% |
Varonis Systems Inc | Information Technology | 1.9% |
Agilysys Inc | Information Technology | 1.9% |
Zeta Global Holdings Corp | Information Technology | 1.9% |
Crane Co | Industrials | 1.9% |
Appfolio Inc | Information Technology | 1.8% |
Loar Holdings Inc | Industrials | 1.8% |
Onto Innovation Inc | Information Technology | 1.8% |
FTAI Aviation Ltd | Industrials | 1.7% |
Blueprint Medicines Corp | Health Care | 1.7% |
Sweetgreen Inc | Consumer Discretionary | 1.7% |
Insmed Inc | Health Care | 1.7% |
Comfort Systems USA Inc | Industrials | 1.7% |
Freshpet Inc | Consumer Staples | 1.7% |
ADMA Biologics Inc | Health Care | 1.6% |
Hamilton Lane Inc | Financials | 1.6% |
SPS Commerce Inc | Information Technology | 1.6% |
MakeMyTrip Ltd | Consumer Discretionary | 1.6% |
Credo Technology Group Holding Ltd | Information Technology | 1.6% |
Parsons Corp | Industrials | 1.5% |
Evercore Inc | Financials | 1.5% |
Krystal Biotech Inc | Health Care | 1.4% |
Intra-Cellular Therapies Inc | Health Care | 1.4% |
Natera Inc | Health Care | 1.4% |
Wix.com Ltd | Information Technology | 1.4% |
Camtek Ltd/Israel | Information Technology | 1.4% |
Guidewire Software Inc | Information Technology | 1.4% |
Monday.com Ltd | Information Technology | 1.3% |
Wingstop Inc | Consumer Discretionary | 1.3% |
Arcellx Inc | Health Care | 1.3% |
Itron Inc | Information Technology | 1.3% |
SpringWorks Therapeutics Inc | Health Care | 1.3% |
Bright Horizons Family Solutions Inc | Consumer Discretionary | 1.3% |
RxSight Inc | Health Care | 1.3% |
Sprouts Farmers Market Inc | Consumer Staples | 1.2% |
Lantheus Holdings Inc | Health Care | 1.2% |
Modine Manufacturing Co | Consumer Discretionary | 1.2% |
AeroVironment Inc | Industrials | 1.2% |
Stride Inc | Consumer Discretionary | 1.2% |
SPX Technologies Inc | Industrials | 1.1% |
Merus NV | Health Care | 1.1% |
Oddity Tech Ltd | Consumer Staples | 1.1% |
Vertex Inc | Information Technology | 1.1% |
Sterling Infrastructure Inc | Industrials | 1.1% |
Impinj Inc | Information Technology | 1.1% |
Descartes Systems Group Inc/The | Information Technology | 1.0% |
Verra Mobility Corp | Industrials | 1.0% |
Tetra Tech Inc | Industrials | 1.0% |
Fabrinet | Information Technology | 0.9% |
Crinetics Pharmaceuticals Inc | Health Care | 0.9% |
REVOLUTION Medicines Inc | Health Care | 0.9% |
Birkenstock Holding Plc | Consumer Discretionary | 0.9% |
Reddit Inc | Communication Services | 0.9% |
PROCEPT BioRobotics Corp | Health Care | 0.9% |
Baldwin Insurance Group Inc/The | Financials | 0.8% |
Nova Ltd | Information Technology | 0.8% |
nVent Electric PLC | Industrials | 0.8% |
Maplebear Inc | Consumer Staples | 0.8% |
Doximity Inc | Health Care | 0.8% |
Moog Inc | Industrials | 0.8% |
Q2 Holdings Inc | Information Technology | 0.8% |
Criteo SA | Communication Services | 0.7% |
MSA Safety Inc | Industrials | 0.7% |
Avidity Biosciences Inc | Health Care | 0.7% |
Primo Water Corp | Consumer Staples | 0.7% |
Life Time Group Holdings Inc | Consumer Discretionary | 0.7% |
Janux Therapeutics Inc | Health Care | 0.7% |
Dyne Therapeutics Inc | Health Care | 0.6% |
Nuvalent Inc | Health Care | 0.6% |
AAON Inc | Industrials | 0.6% |
Vaxcyte Inc | Health Care | 0.6% |
Astera Labs Inc | Information Technology | 0.6% |
Mirum Pharmaceuticals Inc | Health Care | 0.6% |
Clear Secure Inc | Information Technology | 0.6% |
Guardant Health Inc | Health Care | 0.5% |
VSE Corp | Industrials | 0.5% |
Paymentus Holdings Inc | Financials | 0.0% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
Fund Documents
Fund Documents
Portfolio Holdings 1Q
Publish Date:11/03/2015
|
||||
Portfolio Holdings 3Q
Publish Date:11/03/2015
|
||||
Summary Prospectus
Publish Date:11/03/2015
|
||||
Statutory Prospectus
Publish Date:11/03/2015
|
||||
SAI
Publish Date:11/03/2015
|
||||
Annual Financial Statements and Other Information *
Publish Date:11/03/2015
|
||||
Semi-Annual Financial Statements and Other Information *
Publish Date:11/03/2015
|
||||
Fact Sheet
Publish Date:11/03/2015
|
Other Important Information
Portfolio shares of the Lord Abbett Series Funds are not offered directly to the public. These shares are currently offered only to separate accounts of certain insurance companies that are unaffiliated with Lord Abbett.
The Fund's portfolio is actively managed and is subject to change. Holdings are for informational purposes only and are not a recommendation to buy, sell, or hold any security.
The investment return and principal value of an investment in the Fund will fluctuate so that shares, on any given day or when redeemed, may be worth more or less than their original cost. To obtain performance data current to the most recent quarter-end, go to quarter ending performance on our Website or call Lord Abbett at (888) 522-2388.
Investors should carefully consider the investment objectives, risks charges and expenses of the Lord Abbett Funds. This and other important information is contained in the fund's summary prospectus and/or prospectus. To obtain a prospectus or summary prospectus on any Lord Abbett mutual fund, you can click here, contact your investment professional or Lord Abbett Distributor LLC at (888) 522-2388. Read the prospectus carefully before you invest or send money.